ARDX ARDELYX, INC.

Nasdaq ardelyx.com


$ 5.07 $ -0.11 (-2.23 %)    

Thursday, 16-Oct-2025 16:32:30 EDT
QQQ $ 598.78 $ -5.24 (-0.87 %)
DIA $ 459.01 $ -3.77 (-0.81 %)
SPY $ 659.58 $ -6.23 (-0.93 %)
TLT $ 91.30 $ 0.85 (0.94 %)
GLD $ 396.94 $ 5.21 (1.33 %)
$ 5.13
$ 5.17
$ 5.06 x 9
$ 5.20 x 1
$ 5.01 - $ 5.27
$ 3.21 - $ 6.78
3,015,052
na
1.24B
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 03-02-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-08-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-06-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 03-06-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 03-14-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 02-17-2017 12-31-2016 10-K
36 11-07-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-04-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ardelyx-appoints-sue-hohenleitner-cfo-effective-nov-4

WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a missi...

 piper-sandler-maintains-neutral-on-ardelyx-raises-price-target-to-9

Piper Sandler analyst Christopher Raymond maintains Ardelyx (NASDAQ:ARDX) with a Neutral and raises the price target from $8...

 wedbush-maintains-outperform-on-ardelyx-raises-price-target-to-14

Wedbush analyst Laura Chico maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $13 to $14.

 raymond-james-maintains-outperform-on-ardelyx-raises-price-target-to-12

Raymond James analyst Ryan Deschner maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $11 t...

 ardelyx-q2-eps-008-beats-012-estimate-sales-97662m-beat-82208m-estimate

Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 34...

 hc-wainwright--co-assumes-ardelyx-at-buy-announces-price-target-of-10

HC Wainwright & Co. analyst Matthew Caufield assumes Ardelyx (NASDAQ:ARDX) with a Buy rating and announces Price Target ...

 ardelyx-q1-gaap-eps-017-misses-012-estimate-sales-7411m-miss-7880m-estimate

Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.12) by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION